Your session is about to expire
← Back to Search
Electrical Stimulation
Two Unit TENS for Period Pain
N/A
Waitlist Available
Led By Todd Schroeder, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial will test whether a TENS device can help relieve pain for people with primary dysmenorrhea, by comparing pain levels with and without the device.
Eligible Conditions
- Period Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Analgesic effects of TENS on primary dysmenorrhea.
Secondary outcome measures
Change in analgesic pill consumption during menstruation
Other outcome measures
The surface area of TENS pain relief
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Two Unit TENSExperimental Treatment1 Intervention
Participants will use a two-unit TENS set-up where the TENS unit has 4 channels.
Group II: One Unit TENSExperimental Treatment1 Intervention
Participants will use one-unit TENS set-up where the TENS unit has 2 channels.
Group III: ControlActive Control1 Intervention
During the control condition cycle (no TENS), participants will refrain from using or taking other analgesics, besides ibuprofen.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
One Unit TENS
2022
N/A
~50
Two Unit TENS
2022
N/A
~50
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
915 Previous Clinical Trials
1,603,680 Total Patients Enrolled
Todd Schroeder, PhDPrincipal InvestigatorAssociated Professor
3 Previous Clinical Trials
119 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger